Vidwan-ID : 169369



  • Dr V V S Rajendra Prasad

  • Professor
  • Vishnu Institute of Pharmaceutical Education and Research
Publications 2006 - 2021

Publications

  • 29
    Journal Articles
  • 6
    Projects

Citations / H-Index

270 Citations
9 h-index
216 Citations

Altmetrics

3
62

Google Scholar

Co-author Network


Expertise

Medicinal Chemistry

Extensive training and experience in drug design and discovery, organic synthesis, medicinal and pharmaceutical chemistry. Expertise in operation of modern analytical techniques used in drug discovery and mechanistic studies and modern separation and characterization techniques.

Personal Information

Dr V V S Rajendra Prasad

Male
Department of Pharmaceutical Analysis, Vishnu Institute of Pharmaceutical Education and Research Vishnu Institute of Pharmaceutical Education and Research, Narsapur
Medak, Telangana, India - 502313


Experience

  • Professor

    undefined

    Vishnu Institute of Pharmaceutical Education and Research

  • Professor

    Pharmaceutical Analysis

    Vishnu Institute of Pharmaceutical Education and Research

  • Professor

    Pharmaceutical Analysis

    Vishnu Institute of Pharmaceutical Education and Research

  • Professor

    Department of Pharmaceutical Chemistry and Analysis

    Vishnu Institute of Pharmaceutical Education and Research


Qualification

  • Post Doctoral Experiance

    VU University Medical Center, Amsterdam, The Netherands

  • Ph.D

    Rajiv Gandhi University of Health Sciences

  • M.Pharm

    VL College of Pharmacy

  • B.Pharm

    NET College of Pharmacy


Honours and Awards

2015

SIPRA Innovation Award

SIPRA LABS LIMITED

2012

Career Award for Young Teachers (CAYT)

AICTE India

2015

SIPRA Innovation Award

SIPRA LABS LIMITED

2012

Career Award for Young Teachers (CAYT)

AICTE India

Read Less

Doctoral Theses Guided

2021

Design, synthesis of pyrazoles as inhibitors of aurora kinase and their cytotoxic studies in cancer cells

P Harathi, JNTU Hyderabad

2021

Design, Synthesis of quinazoline derivatives as inhibitors of jak2 and their cytotoxic studies in cancer cells

B.Siva Jyothi, JNTU Hyderabad

2016

Design And Synthesis Of Nitric Oxide Donating Acridone Derivatives As Chemosensitizing Agents In Cancer Cells

G Deepak Reddy, Jawaharlal Nehru Technological University

Read More
2021

Design, synthesis of pyrazoles as inhibitors of aurora kinase and their cytotoxic studies in cancer cells

P Harathi, JNTU Hyderabad

2021

Design, Synthesis of quinazoline derivatives as inhibitors of jak2 and their cytotoxic studies in cancer cells

B.Siva Jyothi, JNTU Hyderabad

2016

Design And Synthesis Of Nitric Oxide Donating Acridone Derivatives As Chemosensitizing Agents In Cancer Cells

G Deepak Reddy, Jawaharlal Nehru Technological University

2016

Development and Validation of Stability Indicating High Performance Liquid Chromatography Method to quantify active pharmaceutical ingredients in solid dosage forms

V.Venkateswararao, Jawaharlal Nehru Technological University

2011

DEVELOPMENT AND VALIDATION OF NEW & IMPROVED ANALYTICAL METHODS FOR EVALUATION OF SOME ANTI CANCER & ANTI FUNGAL DRUGS AND THEIR DOSAGE FORMS BY HPLC & UpLC

G Naveen Kumar Reddy, CMJ University

Read Less

Membership In Professional Bodies

2018

IPA

Life Member

2009

APTI

Life Member

2018

IPA

Life Member

2009

APTI

Life Member

Read Less

Research Projects

Development of Nitric oxide releasing Quinoline derivatives as inhibitors of doxorubicin resistance in cancer cells

Funding Agency : DST

Project, structural insights to inhibit epidermal growth factor receptor (EGFR) dimerization & activation: panitumumab induced conformational study

Funding Agency : DBT

Design And Synthesis Of Nitric Oxide Donating acridone derivatives as reverters of multidrug resistance (MDR) in cancer cells

Funding Agency : SERB

Read More

Development of Nitric oxide releasing Quinoline derivatives as inhibitors of doxorubicin resistance in cancer cells

Funding Agency : DST

Project, structural insights to inhibit epidermal growth factor receptor (EGFR) dimerization & activation: panitumumab induced conformational study

Funding Agency : DBT

Design And Synthesis Of Nitric Oxide Donating acridone derivatives as reverters of multidrug resistance (MDR) in cancer cells

Funding Agency : SERB

Design, Synthesis of quinazoline tagged Acridones and their cytotoxic studies in drug sensitive, resistant cells

Funding Agency : AICTE

Nitric oxide releasing Quinilones derivatives as inhibitors of doxorubicine resistance in cancer

Funding Agency : AICTE

Development of an affordable test kit for early detection of colon cancer and GIT disorders

Funding Agency : MSME

Read Less

Patents



Read Less